Executive VP of Vision Science, Dr. Len Zheleznyak, to present performance data on the world's only diffractive multifocal soft contact lens and new findings on the "Optical Signatures" of myopia ...
ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.
CAMPBELL, Calif.--(BUSINESS WIRE)--Body Vision Medical, a leader in AI-driven, intraoperative image guidance, today announced that its LungVision® system has been selected as the winner of the “Best ...
Medical Device Network on MSN
ReVision Implant eyes FIH trial for BCI after FDA breakthrough designation
ReVision now anticipates initiating early-stage human clinical trials of its Occular BCI in blind volunteers in 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results